← All trials
NCT04946370
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 12, 2021
- Primary completion
- Jun 30, 2025
- Completion date
- Jun 30, 2028
- First posted
- Jun 30, 2021
- Last posted
- Sep 27, 2021
- Enrollment
- 76
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cornell UniversityLead sponsor
- Cornell UniversityOverall official - principal investigator
- MerckCollaborator
- Department of DefenseCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.